183 related articles for article (PubMed ID: 32149760)
1. Intracoronary pressure gradient measurement in acute myocardial infarction patients with the no-reflow phenomenon during primary percutaneous coronary intervention.
Gao MD; Zhang EY; Liu YY; Li XW; Xiao JY; Sun GY; Liu Y
Chin Med J (Engl); 2020 Apr; 133(7):766-772. PubMed ID: 32149760
[TBL] [Abstract][Full Text] [Related]
2. Effect of intracoronary administration of anisodamine on slow reflow phenomenon following primary percutaneous coronary intervention in patients with acute myocardial infarction.
Fu XH; Fan WZ; Gu XS; Wei YY; Jiang YF; Wu WL; Li SQ; Hao GZ; Wei QM; Xue L
Chin Med J (Engl); 2007 Jul; 120(14):1226-31. PubMed ID: 17697572
[TBL] [Abstract][Full Text] [Related]
3. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
4. Comparison of the effects of nitroprusside versus nicorandil on the slow/no-reflow phenomenon during coronary interventions for acute myocardial infarction.
Kobatake R; Sato T; Fujiwara Y; Sunami H; Yoshioka R; Ikeda T; Saito H; Ujihira T
Heart Vessels; 2011 Jul; 26(4):379-84. PubMed ID: 21110199
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Slow-Flow After Primary Percutaneous Coronary Intervention With Flow-Mediated Hyperemia: The Randomized RAIN-FLOW Study.
Gomez-Lara J; Gracida M; Rivero F; Gutiérrez-Barrios A; Muntané-Carol G; Romaguera R; Fuentes L; Marcano A; Roura G; Ferreiro JL; Teruel L; Brugaletta S; Alfonso F; Comín-Colet J; Gomez-Hospital JA
J Am Heart Assoc; 2023 Jul; 12(13):e030285. PubMed ID: 37345805
[TBL] [Abstract][Full Text] [Related]
6. [Effect of urapidil on heart function and ventricular systolic synchrony in acute myocardial infarction patients with no-reflow phenomenon after percutaneous coronary intervention].
Chen JL; Fu XH; Jiang YF; Fan WZ; Gu XS; Liu JJ; Geng W
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Apr; 20(4):197-9. PubMed ID: 18419949
[TBL] [Abstract][Full Text] [Related]
7. Acute Effects of Intracoronary Tirofiban on No-Reflow Phenomena in Patients With ST-Segment Elevated Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Akpek M; Sahin O; Sarli B; Baktir AO; Saglam H; Urkmez S; Ergin A; Oguzhan A; Arinc H; Kaya MG
Angiology; 2015 Jul; 66(6):560-7. PubMed ID: 25092681
[TBL] [Abstract][Full Text] [Related]
8. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Geng N; Ren L; Xu L; Zou D; Pang W
BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
11. [Effects of intracoronary diltiazem on no-reflow phenomenon after emergent percutaneous coronary intervention in patients with acute myocardial infarction].
Zheng ZF; Pu XQ; Yang TL; Li CC; Peng DD; Yu ZX; Mo L; Chen XB
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Dec; 31(6):917-20. PubMed ID: 17213597
[TBL] [Abstract][Full Text] [Related]
12. Intracoronary epinephrine in the treatment of refractory no-reflow after primary percutaneous coronary intervention: a retrospective study.
Aksu T; Guler TE; Colak A; Baysal E; Durukan M; Sen T; Guray U
BMC Cardiovasc Disord; 2015 Feb; 15():10. PubMed ID: 25885120
[TBL] [Abstract][Full Text] [Related]
13. Effect of combined intracoronary adenosine and nicorandil on no-reflow phenomenon during percutaneous coronary intervention.
Lim SY; Bae EH; Jeong MH; Kang DG; Lee YS; Kim KH; Lee SH; Yoon KH; Hong SN; Park HW; Hong YJ; Kim JH; Kim W; Ahn YK; Cho JG; Park JC; Kang JC
Circ J; 2004 Oct; 68(10):928-32. PubMed ID: 15459466
[TBL] [Abstract][Full Text] [Related]
14. Intracoronary streptokinase after primary percutaneous coronary intervention.
Sezer M; Oflaz H; Gören T; Okçular I; Umman B; Nişanci Y; Bilge AK; Sanli Y; Meriç M; Umman S
N Engl J Med; 2007 May; 356(18):1823-34. PubMed ID: 17476008
[TBL] [Abstract][Full Text] [Related]
15. Prevention of no flow/slow reflow phenomenon in primary PCI by Nicorandil.
J E; Juneja MS; George T; Sr R; V V; Ak B; Kalyani S; Pandurangi UM; Latchumanadhas K; S MA
Indian Heart J; 2007; 59(3):246-9. PubMed ID: 19124934
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of the no-reflow phenomenon after coronary angioplasty for acute myocardial infarction with intracoronary papaverine.
Ishihara M; Sato H; Tateishi H; Kawagoe T; Shimatani Y; Kurisu S; Sakai K
Am Heart J; 1996 Nov; 132(5):959-63. PubMed ID: 8892767
[TBL] [Abstract][Full Text] [Related]
17. Angiographic patterns of myocardial reperfusion after primary angioplasty and ventricular remodeling.
Niccoli G; Cosentino N; Lombardo A; Sgueglia GA; Spaziani C; Fracassi F; Cataneo L; Minelli S; Burzotta F; Maria Leone A; Porto I; Trani C; Crea F
Coron Artery Dis; 2011 Nov; 22(7):507-14. PubMed ID: 21857508
[TBL] [Abstract][Full Text] [Related]
18. Effect of high-dose intracoronary adenosine administration during primary percutaneous coronary intervention in acute myocardial infarction: a randomized controlled trial.
Fokkema ML; Vlaar PJ; Vogelzang M; Gu YL; Kampinga MA; de Smet BJ; Jessurun GA; Anthonio RL; van den Heuvel AF; Tan ES; Zijlstra F
Circ Cardiovasc Interv; 2009 Aug; 2(4):323-9. PubMed ID: 20031735
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
20. The relationship between attenuated plaque identified by intravascular ultrasound and no-reflow after stenting in acute myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
Wu X; Mintz GS; Xu K; Lansky AJ; Witzenbichler B; Guagliumi G; Brodie B; Kellett MA; Dressler O; Parise H; Mehran R; Stone GW; Maehara A
JACC Cardiovasc Interv; 2011 May; 4(5):495-502. PubMed ID: 21596321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
